Pangen Biotech Inc.
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
222110 | KO
Overview
Corporate Details
- ISIN(s):
- KR7222110009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) , 수원시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pangen Biotech Inc. is a global biotechnology company specializing in the research, development, and manufacturing of biologics. The company's core business focuses on developing and commercializing high-growth biosimilar products, including Erythropoietin (EPO) and Aflibercept. Leveraging its patented platform technology centered on Chinese Hamster Ovary (CHO) cell lines, Pangen Biotech also provides comprehensive Contract Development and Manufacturing Organization (CDMO) services to other biopharmaceutical firms. The company, part of the Huons Group, aims to supply both domestic and international markets with its biologics, reagents, and development services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 77.4 KB | ||
| 2025-08-20 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
|
Korean | 11.0 KB | ||
| 2025-08-20 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2025-08-13 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.5 MB | ||
| 2025-08-13 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.2 MB | ||
| 2025-07-25 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-05-20 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 17.3 KB | ||
| 2025-05-16 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 92.5 KB | ||
| 2025-05-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.6 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-05-12 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.8 KB | ||
| 2025-05-02 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 40.9 KB | ||
| 2025-04-28 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB |
Automate Your Workflow. Get a real-time feed of all Pangen Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pangen Biotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pangen Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
